Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure
The facility sets a new benchmark in respiratory diagnostics
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets
The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
